Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 6, 2007, Pages 65-80

  Jaworek, J ^a   Nawrot Porabka, K ^a   Leja Szpak, A ^a   Bonior, J ^a   Szklarczyk, J ^a   Kot, M ^a   Konturek, S J ^a   Pawlik, W W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute pancreatitis; Amylase secretion; L tryptophan; Melatonin

Indexed keywords

CHOLECYSTOKININ; KETANSERIN; MELATONIN; PANCREAS ENZYME; SEROTONIN ANTAGONIST; TRYPTOPHAN;

ACUTE PANCREATITIS; DRUG DOSE INCREASE; DRUG EFFECT; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; VAGOTOMY;

ACUTE DISEASE; AMYLASES; ANIMALS; CAERULEIN; CHOLECYSTOKININ; FREE RADICAL SCAVENGERS; GASTROINTESTINAL TRACT; MELATONIN; PANCREAS; PANCREATITIS; RECEPTOR, CHOLECYSTOKININ A; REPERFUSION INJURY; TRYPTOPHAN;

EID: 38149134547     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Lerner AB, Case JD, Lee TH, Mori W. Isolation of melatonin, the pineal factor, that lightens melanocytes. J Am Chem Sci 1958, 80: 2587.
2. Stefluj J, Horner M, Ghosh M et al. Gene expression of the key enzymes in melatonin synthesis in extrapineal tissues in the rat. J Pineal Res 2001; 30: 243-247.
3. Lincoln GA, Clarke IJ, Hut RA, Hazlerigg DG. Characterizing a mammalian circannual pacemarker. Scince 2006; 314 (507): 1941-1944.
4. Barron ML. Light exposure, melatonin secretion, and menstrual cycle parameters: an integrative review. Biol Res Nurs 2007: 9: 49-69.
5. Sharkey KM, Eastman CI. Melatonin phase shifts circadian rhythms in a placebo-controlled stimulated night-work study. Am J Physiol 2002; 282: R454-R463.
6. Perreau-Lentz S, Kalsbeek A, Garidou ML et al. Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanism. Eur J Neurosci 2003; 17: 221-228.
7. Suzen S. Recent developments of melatonin related antioxidant compounds. Comb Chem High Throughput Screen 2006; 9: 409-19.
8. Symons AM, King LJ. Inflammation, reactive oxygen species and cytochrome P450. Inflammopharmacology 2003; 1: 75-86.
9. Alfonso V, Champt R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: role in joint disease. Joint Bone Spine 2007; 74: 324-329.
10. Shi C, Andersson R, Zhao X, Wang X. Potential role of oxygen species in pancreatitis-associated multiple organ dysfunction. Pancreatology 2005; 5; 492-500.
11. Modzelewski B, Janiak A. Lipid peroxidation products as prognostic factors in acute pancreatits. Pol Merkur Lekarski 2005; 19: 511-513.
12. Da̧browski A, Konturek JW, Konturek SJ, Gabryelewicz A. Role of oxidative stress in the pathogenesis of caerulein-induced pancreatitis. Eur J Pharmacol 1999; 377: 1-11.
13. Rodriquez C, Mayo JC, Sainz RM et al. Regulation of antioxidative enzymes; a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
14. Costa EJX, Lopez RH, Lamy-Freund MT. Solubility of pure bilayers to melatonin. J Pineal Res 1995; 19: 123-126.
15. Miller SC, Pandi-Perumal SR, Esquifino AI, Cardinali DP, Maestroni GJ. The role of melatonin in immuno-enhancement: potential application in cancer. Int Exp Pathol 2006; 87: 81-87.
16. Carillo-Vico A, Reiter RJ, Ladone PJ, Herrera JL et al. The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs 2006; 7: 423-431.
17. Paredes SD, Sanchez S, Parvez H, Rodriquez AB, Barriga C. Altered circadian rhythms of corticosterone, melatonin, and phagocytic activity in response to stress in rats. Neuro Endocrinol Lett 2007; 11; 28.
18. Brennan CP, Hendrick GL, El Sheikh TM, Mashaly MM. Melatonin and the enhancement of immune response in immaturate male chicken. Poult Res 2002; 81: 371-375.
19. Kuhlvein E, Irvin M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cell cytokine expression. J Neuroimmunol 2001; 117: 51-57.
20. Garcia-Maurino S, Pozo D Calvo JR et al. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res. 2000; 29: 129-137.
21. Huether G, Poeggler B, Reimer A et al. Effects of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992; 51: 945-953.
22. Yaga K, Reiter RJ, Richardson BA. Tryptophan loading increases daytime serum melatonin levels in intact and pinealectomized rats. Life Sci 1993; 52: 1231-1238.
23. Bubenik GA, Brown GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of the rats. Biol Signals 1997; 6: 40-44.
24. Bubenik GA. Gastrointestinal melatonin: localization, function and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348.
25. Bubenik GA, Hacker RR, Brown GM et al. Melatonin concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 1999; 29: 56-63.
26. Jaworek J, Leja-Szpak A, Bonior J et al. Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003; 34: 40-52.
27. Bubenik GA, Pang SF, Hacker RR et al. Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 1996; 24: 251-256.
28. Caniato R, Filippini R, Piovan A et al. Melatonin in plants. Adv Exp Med Biol 2003; 527: 593-597.
29. Hattori A, Migitaka H, Iiho M et al. Identification of melatonin in plants and its effect on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int. 1995; 35: 627-634.
30. Raikhlin NT, Kvetnoy IM, Tolkahev VN. Melatonin may be synthetized in enterochromaffine cells. Nature 1975; 255: 344-345.
31. Tan DX, Manchester LC, Reiter RJ et al. High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65: 2523-2529.
32. Messner M, Huether G, Lorf T et al. Presence of melatonin in the human hepatobiliary tract. Life Sci 2001; 69: 543-551.
33. Stebelova K, Herichova I, Zeman M. Diabetes induces changes in melatonin concentration in peripheral tissues of rat. Neuro Endocrinol Lett 2007; 28:159-165.
34. Peschke E, Bach AG, Muhlbauer E. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res. 2006; 40: 184-191.
35. Peschke E, Stumpf I, Bazwinsky I, Litvak L, Dralle H, Muhlbauer E. Melatonin and type 2 diabetes - a possible link? J Pineal Res 2007; 42: 350-358.
36. Jaworek J, Nawrot K, Konturek SJ et al. Melatonin and its precursor; L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 2004; 36: 156-164.
37. Leja-Szpak A, Jaworek J, Nawrot K et al. Modulation of pancreatic enzyme secretion by melatonin and its precursor; L-tryptophan. Role of CCK and afferent nerves. J Physiol Pharmacol 2004; 55: 441-451.
38. Jaworek J. Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006; 57: 83-96.
39. Li Y, Owyang C. High affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in the rat. Am J Physiol 1997; 273: G679-G685.
40. Niebergall-Roth E, Siger MV. Enteropancreatic reflexes mediating the pancreatic enzyme response to nutriens. Auton Neurosci 2006; 30: 62-69.
41. Li Y, Hao Y, Zhu J, Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 2000; 118: 1197.
42. Li Y, Wu X, Zhu J, Yan J, Owyang C. Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. J Physiol 2003; 52: 571-587.
43. Jaworek J, Konturek SJ. Szlachcic A. The role of CGRP and afferent nerves in the modulation of pancreatic enzyme secretion in the rat. Int J Pancretol 1997; 22: 137-146.
44. Jaworek J, Bonior J, Leja-Szpak A et al Sensory nerves in the central and peripheral control of pancreatic integrity by leptin and melatonin. J Physiol Pharmacol 2002; 53: 51-74.
45. Rezzani R, Buffoli B, Rodelia R, Stacchiotti A, Bianchi R. Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver. Int J Immunopharmacol 2005; 5: 1397-1405.
46. Kurcer Z, Oguz E, Ozbilge H et al. Melatonin protects from ischemia/reperfusion renal injury in rats: this effect is not mediated by proinflammatory cytokines. J Pineal Res 2007; 43: 172-178.
47. Rodriguez MI, Escames G, Lopez LC et al. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescense-accelerated mice. J Pineal Res 2007; 42: 1272-279.
48. Brzozowska I, Konturek PCh, Brzozowski T et al. Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing by melatonin and its precursor. J Pineal Res 1002; 32: 149-162.
49. Chen Z, Chua C, Gao J et al. Protective effect of melatonin on myocardial infarction. Am J Physiol 2003; 284: H1618-1624.
50. Qi W, Tan RX, Reiter RJ et al. Melatonin reduces lipid peroxidation and tissue edema in caerulein-induced acute pancreatitis in the rats. Dig Dis Sci 1999; 44: 2257-2262.
51. Jaworek J, Konturek SJ, Tomaszewska R et al. The circadian rhythm of melatonin modulates the severity of caerulein-induced pancreatitis in the rat. J Pineal Res 2004; 37: 161-170.
52. Dominiques-Rodriques A, Abreu-Gonzales P, Garcia M et al. Light/dark patterns of interleukin 6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26: 89-93.
53. Leja-Szpak A. Jaworek J, Nawrot K et al. Melatonin precursor; L-tryptophan protects the pancreas from development of acute pancreatitis though the central site of action. J Physiol Pharmacol 2004; 55: 239-254.
54. Esrefouglu M, Gul M, Ates B, Selimoglu MA. Ultrastructural clues for the protective effect of melatonin against oxidative damage in caerulein-induced pancreatitis. J Pineal Res 2006; 40: 92-97.
55. Szabolcs A, Reiter RJ, Letoha T et al. Effect of melatonin on the severity of L-arginine-induced experimental pancreatitis in rats. World J Gastroenterol 2006; 12: 251-258.
56. Munoz-Casares FC, Padillo FJ, Briceno J et al. Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J Pineal Res 2006; 40: 195-203.
57. Chen HM, Hsu JT, Chen JC, Ng CJ, Chiu DF, Chen MF. Delayed neutrophil apoptosis attenuated ny melatonin in human acute pancreatiti. Pancreas 2005; 31: 360-364.
58. Chen HM, Chen JC, Ng CJ, Chiu DF, Chen MF. Melatonion reduces pancreatic prostaglandins production and protects against caerulein-induced pancreatitis in rats. J Pineal Res 2006; 40: 34-39.
59. Barlas A, Cevik H, Arbak S et al. Melatonin protects against pancreatobiliary inflammation and associated remote organ injury in rats: role of neutophils. J Pineal Res 2004; 37: 267-275.
60. Ting AN, Black NA, Sugden D et al. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol 1999; 127: 987-995.
61. Bonior J, Jaworek J, Konturek SJ, Pawlik WW. Increase of heat shock protein gene expression by melatonin in AR42J cells. J Physiol Pharmacol 2005; 56: 471-481.
62. Dillman WH. Heat shock proteins and protection against ischemic injury. Infect Dis Obstet Gynecol 1999; 7: 55-57.
63. Jaworek J. Konturek SJ, Leja-Szpak A et al. Role of endogenous melatonin and its MT2 receptor In the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53: 791-804
64. Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110.